Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (54)

Latest Posts

About This Stock More About This Stock
Allergan Slides After Goldman Downgrades On Lack Of Catalysts
Article By: The Fly
Wednesday, May 10, 2017 11:47 AM EDT
Shares of Allergan are slipping after Goldman Sachs analyst Jami Rubin downgraded the stock to Neutral, citing its recent run, peaking margins and a lack of near-term catalysts.
In this article: AGN
Read
Allergan Lifts Guidance As Q1 Earnings Beat The Street
Article By: Lorimer Wilson
Tuesday, May 9, 2017 8:53 AM EDT
The Dublin, Ireland-based pharmaceuticals giant, Allergan plc. posted better than expected first quarter earnings results and lifted its full-year outlook, amid strong demand for its facial aesthetics products.
In this article: AGN
Read
Allergan Phase Il Study Of Botox As A Treatment For Major Depression In Women Has Mixed - But Promising - Results
Article By: Lorimer Wilson
Wednesday, April 5, 2017 10:11 PM EDT
Allergan’s Phase II study testing Botox as a treatment for major depression among women missed hitting statistical significance for the primary endpoint at 6 weeks of therapy but did score at a couple of other time points in the study.
In this article: AGN Also: PFE
Read
Ex-CEO And Chairman Of Allergan, Paul Bisaro, Is Taking The Helm At Impax Laboratories Inc
Article By: Lorimer Wilson
Tuesday, March 28, 2017 8:14 AM EDT
After handing over both the CEO and chairman reins at the company now known as Allergan longtime generics chief, Paul Bisaro, is taking the helm at Impax Laboratories Inc.
In this article: AGN, IPXL Also: NVS, TEVA, ABT, MYL
Read
Allergen/Paratek Acne Treatment Drug Passes Both Phase III Studies, Foamic Scores A Split
Article By: Lorimer Wilson
Monday, March 27, 2017 4:57 PM EDT
Allergan’s partnership with Paratek is part of an ambitious effort to buy or partner up on a long range of experimental therapies for each of its core focus areas. The Botox maker has made a big investment in aesthetics and dermatology.
In this article: AGN Also: FOMX, PRTK
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 1 of 1 comments